Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
BGLC
#8992
BioNexus Gene Lab Corp Common stock
2.265
0
USD
-2.37%
Settore:
Materiali di Base
Base:
USD
Valuta di Profitto:
USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-2.37%
Variazione Mensile
+0.89%
Variazione di 6 mesi
+0.89%
Variazione Annuale
+0.89%
Chiusura Precedente
2.320
0
Open
2.236
0
Bid
2.265
0
Ask
2.268
0
Low
2.230
0
High
2.299
9
Volume
7
Mercati
Mercato Azionario Statunitense
Materiali di Base
BGLC
Open full chart
Financials
Overview
Estratto Conto
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
1.8 M
17.97 M
1.8 M
1.8 M
1.8 M
—
Valuation ratios
Enterprise value
—
—
—
5.52 M
9.83 M
—
Price to earnings ratio
—
—
—
—
-24.75
—
Price to sales ratio
—
—
—
—
1.86
—
Price to cash flow ratio
—
—
—
—
-4.79
—
Price to book ratio
—
—
—
—
0.62
—
Enterprise value to EBITDA ratio
—
—
—
0.86
1.85
—
Profitability ratios
Return on assets %
-0.12
-0.03
-0.07
-0.07
-0.09
-0.26
Return on equity %
-0.14
-0.04
-0.08
-0.08
-0.1
-0.31
Return on invested capital %
-67.8
-19.74
-34
—
—
—
Gross margin %
12.41
12.25
16.07
16.28
14.85
59.45
Operating margin %
-50.85
-16.49
-28.94
-27.05
-27.62
-100.09
EBITDA margin %
-67.25
298.41
68.48
-35.08
-113.53
218.28
Net margin %
-51.15
-13.8
-29.17
-27.26
-27.87
-98.1
Liquidity ratios
Quick ratio
3.99
3.1
3.44
2.94
6.81
16.28
Current ratio
4.98
3.81
4.19
3.63
8.3
19.93
Inventory turnover
—
0.03
0.01
0.01
0.02
0.08
Asset turnover
0.24
0.24
0.21
0.24
0.3
0.99
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
0
-0.05
-0.41
-0.69
-1.14
EBIT per share
—
0.42
0.08
-0.46
-0.45
-0.41
EBITDA per share
—
0.42
0.08
-0.44
-1.61
-1.54
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.09
0.06
—
—
—
Net current asset value per share
—
0.42
0.36
3.55
3.13
7.46
Tangible book value per share
—
0.47
0.43
4.19
3.79
8.88
Working capital per share
—
0.31
0.28
2.57
2.75
5.91
Book value per share
—
0.47
0.43
4.19
3.79
8.88
Notizie
BioNexus Gene Lab nomina direttore commerciale presso Fidelion
BioNexus Gene Lab appoints commercial officer at Fidelion
BioNexus Gene Lab completa accordo strategico con Fidelion Diagnostics
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics
Le azioni di BioNexus Gene Lab scendono dopo accordo da 500 milioni
BioNexus Gene Lab stock falls after securing $500M equity facility
BioNexus Gene Lab secures $500 million equity purchase agreement
Le azioni di BioNexus Gene Lab salgono dopo aver ottenuto 500 milioni di dollari
BioNexus Gene Lab stock climbs after securing $500 million equity facility
BioNexus Gene Lab forma partnership per commercializzare piattaforma di biopsia liquida
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform
Le azioni di BioNexus Gene Lab salgono dopo accordi strategici sui test MRD